Results: 4

Clinical and economic aspects of the use of rituximab in non-Hodgkin's lymphoma

Braz. j. pharm. sci; 50 (3), 2014
Non-Hodgkin's lymphoma (NHL) consists of a group of neoplasias involving mainly B cells and represents 90% of all lymphomas. The current available therapy is based on chemotherapy associated with the monoclonal antibody rituximab (Mab Thera(r)), which targets the CD20 protein, present in over 80% of NHL ...

Laparatomía estadiadora en linfoma de Hodgkin
Staging laparatomy in Hodgkin's lymphoma

Arch. Hosp. Vargas; 33 (3/4), 1991
Se revisaron todas las historias bajo la codificación de Linfoma Hodgkin que ingresaron al Hospital Vargas, entre los años 1974 a 1990, con un total de 117 pacientes. De ellos 21 pacientes fueron sometidos a laparatomía estadiadora, los estadios clínicos fueron: estadio III 39,09%, estadio II 33,33% ...